Market Research Logo

ImmuCell Corporation (ICCC) - Financial and Strategic SWOT Analysis Review

ImmuCell Corporation (ICCC) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ImmuCell Corporation (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the dairy and beef industries. The company focuses on the prevention, diagnosis and treatment of bovine diseases. The company’s major products include First Defense bovine coronavirus-escherichia coli antibody; Wipe Out dairy wipes; and California Mastitis Test (CMT). Immucell is also developing Mast Out, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company has developed its products based on the requirement in two areas, namely, Intelligent Mastitis Management and Calf Health. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Maine, the US.

ImmuCell Corporation Key Recent Developments

May 11, 2016: ImmuCell Announces First Quarter 2016 Financial Results
Feb 10, 2016: ImmuCell Announces Full Year 2015 Financial Results
Jan 28, 2016: ImmuCell Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results
Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015
Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
ImmuCell Corporation - Key Facts
ImmuCell Corporation - Key Employees
ImmuCell Corporation - Key Employee Biographies
ImmuCell Corporation - Key Operational Employees
ImmuCell Corporation - Major Products and Services
ImmuCell Corporation - History
ImmuCell Corporation - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
ImmuCell Corporation - Business Description
ImmuCell Corporation - Corporate Strategy
ImmuCell Corporation - SWOT Analysis
SWOT Analysis - Overview
ImmuCell Corporation - Strengths
Strength - Flagship Product First Defense
Strength - Distribution Network
Strength - Robust Technical and Corporate Expertise
ImmuCell Corporation - Weaknesses
Weakness - Dependence on Single Product
ImmuCell Corporation - Opportunities
Opportunity - Growth Potential: Mastitis
Opportunity - Veterinary Market
Opportunity - Strategic Initiatives
ImmuCell Corporation - Threats
Threat - Stiff Competition
Threat - Bovine Diseases
Threat - Stringent Regulations
ImmuCell Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
ImmuCell Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015
Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015
May 12, 2015: ImmuCell Announces Results for First Quarter of 2015
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ImmuCell Corporation, Key Facts
ImmuCell Corporation, Key Employees
ImmuCell Corporation, Key Employee Biographies
ImmuCell Corporation, Key Operational Employees
ImmuCell Corporation, Major Products and Services
ImmuCell Corporation, History
ImmuCell Corporation, Key Competitors
ImmuCell Corporation, Ratios based on current share price
ImmuCell Corporation, Annual Ratios
ImmuCell Corporation, Interim Ratios
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
ImmuCell Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
ImmuCell Corporation, Performance Chart (2011 - 2015)
ImmuCell Corporation, Ratio Charts
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report